Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ImpactAssets is a nonprofit financial services firm specializing in donor-advised funds (DAFs) focused on impact investing. It channels charitable capital into projects advancing environmentalism, social equity, and economic redistribution. While it is not a biotech, pharma, or healthcare therapeutics company directly, it acts as a platform connecting donors and investors with impact-focused funds, including those in global health, climate, and social equity sectors. As of 2023, it manages over $3 billion in assets and has facilitated more than $1 billion in grants to nonprofits worldwide, with a significant portion of recent investments directed toward climate action and equity initiatives.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ImpactAssets.